Author name: louisam

Children’s Mental Health Week and shortage of ADHD medication

Children’s Mental Health Week and shortage of ADHD medication As the Children’s mental health week finishes a topical subject is ADHD and its management.  For many individuals with ADHD, medication is crucial to their treatment plan and the ongoing shortage of ADHD medications has caused an understandable area of concern. The frustration that the shortages cause …

Children’s Mental Health Week and shortage of ADHD medication Read More »

Xanomeline-trospium, a new treatment for schizophrenia

Xanomeline-trospium, a new treatment for schizophrenia The US Food & Drug Administration (FDA) has accepted a New Drug Application (NDA) for KarXT (xanomeline-trospium) for the treatment of schizophrenia in adults. Xanomeline-trospium a novel pharmacological compound to be considered for the treatment of schizophrenia.  Schizophrenia is a disease of diverse aetiology, involving numerous neurotransmitters (e.g., dopamine, 5-hydroxytryptamine …

Xanomeline-trospium, a new treatment for schizophrenia Read More »

A Ray of Hope for Depression?

A Ray of Hope for Depression? There is research on the potential therapeutic benefits of psychedelics in the treatment of depression. Traditionally associated recreational use, substances like psilocybin (found in magic mushrooms), LSD, and MDMA are now being investigated for their ability to treat depression.   Psychedelic drugs are substances that have a range of psychological …

A Ray of Hope for Depression? Read More »